☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Marketing
NightWare Receives the US FDA's Approval for the First Medical Device to Stop NightMAres Related to PTSD
November 11, 2020
Medicure Signs Agreement with Reliance Life Sciences for Marketing Rights of a Cardiovascular Biosimilar
October 5, 2020
Sun Pharma Reports Submission of Manufacturing and Marketing Authorization Application of Tildrakizumab in Japan
August 1, 2019
Sanofi Reports Results of Cablivi (caplacizumab) in P-III HERCULES Study in Patients with Rare Blood Clotting Disorder- Published...
January 10, 2019
Pharmacosmos' Monoferric 1000 mg IV Receives Health Canada Marketing Approval
September 7, 2018
Celltrion's Herzuma (Herceptin biosimilar) Receives Marketing Approval in Australia
August 3, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.